Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2012

View Archived Issues

Trius Therapeutics synthesizes novel dual-target antibacterial agents

MM-433593 human pharmacokinetic data presented

NEPTUNE I and II data on tamsulosin/solifenacin presented

Ono Pharmaceutical designs novel E-NPP 2 inhibitors

New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes

Further clinical data on dapagliflozin available

Research at Ortho-McNeil-Janssen Pharmaceuticals yields new gamma secretase modulators

Variations in MYH11/NDE1 and MUC16 loci are linked to common epilepsy

Novel candidate anticancer drugs patented

MRC Technology presents new antimalarials

Novel GABA(A) receptor modulators synthesized by team of French researchers

CHMP recommends Bayer's anticoagulant for additional use

Merck Serono to support Auxogyn's fertility test

Tresiba and Ryzodeg receive positive CHMP opinions

Millennium begins phase III MLN-9708 study

A novel derivative of M6G shows analgesic potency

CHMP recommends Abbott's Humira in pediatric Crohn's disease

EMA's CHMP recommends approval of Amyvid

Summit receives second award from the Wellcome Trust for C. difficile antibiotic program

Astellas set to launch Gonax in Japan

BiondVax and MonoSol Rx to collaborate on oral film formulation of universal flu vaccine

Astellas and AIST to collaborate on discovering drugs for neglected tropical diseases

Mirabegron recommended for European approval

TNI BioTech and Hubei Qianjiang Pharmaceuticals to jointly develop anticancer drugs in China

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...